W
AGN

Wealthfront’s Allergan Inc AGN Stock Holding History

Wealthfront’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,676
Closed -$569K – 1311
2014
Q4 		$569K Buy
2,676
+518
+24% +$103K 0.03% 64
2014
Q3 		$385K Buy
2,158
+362
+20% +$60.1K 0.03% 77
2014
Q2 		$304K Buy
1,796
+464
+35% +$72.2K 0.03% 62
2014
Q1 		$165K Buy
+1,332
New +$162K 0.02% 71

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wealthfront's AGN Position: Q1 2015 in Review

Wealthfront sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,676 shares — an estimated $569K sold.

Wealthfront first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $569K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Wealthfront reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Wealthfront sold 2,676 Allergan Inc shares in Q1 2015, an estimated $569K.
  • Wealthfront first reported a position in Allergan Inc in Q1 2014 and held it in 4 quarters.
  • Wealthfront's Allergan Inc position peaked at $569K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Wealthfront's 13F filing for Q1 2015, filed 14 May 2015.